{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:10:05Z","timestamp":1756318205339,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,1,2]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Ovarian cancer is the second most fatal gynaecological malignancy. The relapses after treatment of ovarian cancer usually occur within 2 years after completion of the first-line therapy. Recurrent ovarian cancer commonly presents as peritoneal surface deposits in the abdomen with or without ascites. A delayed relapse presenting as a solitary lesion in the urinary bladder wall is unusual in patients treated for advanced ovarian cancer. We report the successful management of a case of solitary metastasis of ovarian cancer in the urinary bladder wall, which occurred more than 6 years after achieving a complete remission state.<\/jats:p>","DOI":"10.1136\/bcr-2024-262137","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:50:20Z","timestamp":1737319820000},"page":"e262137","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Unusual recurrence in advanced ovarian cancer after interval cytoreductive surgery and HIPEC"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-8708","authenticated-orcid":false,"given":"Shipra","family":"Sonkusare","sequence":"first","affiliation":[{"name":"Gynaecological Oncology, Aster Hospitals Inc, Bangalore, Karnataka, India"},{"name":"Obstetrics & Gynaecology, All India Institute of Medical Sciences - Nagpur, Nagpur, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-1625","authenticated-orcid":false,"given":"Somashekhar","family":"Sampige Prasannakumar","sequence":"additional","affiliation":[{"name":"Surgical Oncology, Aster Hospitals Inc, Bangalore, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Ahuja","sequence":"additional","affiliation":[{"name":"Gynaecological Oncology, Aster Hospitals Inc, Bangalore, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Surgical Oncology, Aster Hospitals Inc, Bangalore, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"key":"2025082710404388000_18.1.e262137.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2025082710404388000_18.1.e262137.2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31819cda77"},{"key":"2025082710404388000_18.1.e262137.3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-37696-5_9"},{"key":"2025082710404388000_18.1.e262137.4","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1016\/S0197-2456(00)00097-0","article-title":"Prostate, lung, colorectal and ovarian cancer screening trial project team","volume":"21","author":"Gohagan","year":"2000","journal-title":"Ctrl Clin Trials"},{"key":"2025082710404388000_18.1.e262137.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.11.015"},{"key":"2025082710404388000_18.1.e262137.6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(02)09738-6","article-title":"Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial","volume":"360","year":"2002","journal-title":"The Lancet"},{"key":"2025082710404388000_18.1.e262137.7","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000007"},{"key":"2025082710404388000_18.1.e262137.8","first-page":"251","article-title":"Splenic metastases in ovarian carcinoma","volume":"36","author":"Khan","year":"1987","journal-title":"West Indian Med J"},{"key":"2025082710404388000_18.1.e262137.9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2009.05.004","article-title":"Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome","volume":"114","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"2025082710404388000_18.1.e262137.10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.33590\/emj\/10312894","article-title":"A Theoretical View of Ovarian Cancer Relapse","volume":"2","author":"Giornelli","year":"2017","journal-title":"EMJ"},{"key":"2025082710404388000_18.1.e262137.11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3126"},{"key":"2025082710404388000_18.1.e262137.12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-021-02145-1","article-title":"Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study","volume":"19","author":"Kamada","year":"2021","journal-title":"World J Surg Onc"},{"key":"2025082710404388000_18.1.e262137.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61268-8"},{"key":"2025082710404388000_18.1.e262137.14","unstructured":"NCCN guidelines version 3.2024 epithelial ovarian cancer\/fallopian tube cancer\/ primary peritoneal cancer. n.d. Available: www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf"},{"key":"2025082710404388000_18.1.e262137.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.08.033"},{"key":"2025082710404388000_18.1.e262137.16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9058-0"},{"key":"2025082710404388000_18.1.e262137.17","article-title":"Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer","volume":"2010","author":"Galaal","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082710404388000_18.1.e262137.18","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2008.0060"},{"key":"2025082710404388000_18.1.e262137.19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22447"},{"key":"2025082710404388000_18.1.e262137.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.09.018"},{"key":"2025082710404388000_18.1.e262137.21","unstructured":"Bois AD , Sehouli J , Vetgote I , et al . Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III\/ENGOT-ov20. J Clin Oncol 2017;38."},{"key":"2025082710404388000_18.1.e262137.22","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1200\/JCO.21.02011","article-title":"Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial","volume":"40","author":"Liu","year":"2022","journal-title":"JCO"},{"key":"2025082710404388000_18.1.e262137.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"2025082710404388000_18.1.e262137.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71135-0"},{"key":"2025082710404388000_18.1.e262137.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.08.004"},{"key":"2025082710404388000_18.1.e262137.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4489"},{"key":"2025082710404388000_18.1.e262137.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.1408"},{"key":"2025082710404388000_18.1.e262137.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70228-1"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-262137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:40:55Z","timestamp":1756316455000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-262137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,19]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bcr-2024-262137"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-262137","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}